Retatrutid 10mg

Retatrutide is a novel peptide drug, a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors. It helps weight loss by regulating appetite, enhancing satiety, and increasing energy expenditure. It also improves cardiovascular-metabolic risk markers like blood pressure, HbA1c, fasting glucose, insulin, cholesterol, and triglycerides, and benefits non-alcoholic fatty liver disease patients by normalizing liver fat. Unlike single or dual agonists, Retatrutid’s triple action offers broader metabolic benefits, making it more effective for weight loss, liver fat reduction, and blood sugar normalization. It’s a promising new choice for obese and type 2 diabetic patients, especially those unresponsive to current treatments.